Capex / revenue moved 596 bp lower
Capex / revenue changed -596 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed -596 basis points from the comparable as-filed period.
Capital expenditure changed -43.3% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Cash & equivalents changed +40.0% from the comparable as-filed period.
Free-cash-flow proxy changed -40.4% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
Net income changed -179.6% from the comparable as-filed period.
Operating cash flow changed -41.7% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Operating income changed -87.9% from the comparable as-filed period.
Operating margin changed -2891 basis points from the comparable as-filed period.
Revenue changed -14.4% from the comparable as-filed period.
Selling, general & administrative changed -10.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.